PCM
TIL icon

Prelude Capital Management’s Instil Bio TIL Stock Holding History

Prelude Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.9K Buy
+10,300
New +$83.6K 0.01% 1077

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Prelude Capital Management's TIL Position: Q1 2026 in Review

Prelude Capital Management opened a new position in Instil Bio (TIL) in Q1 2026: 10,300 shares worth $84.9K. The stake represents 0.01% of the portfolio and ranks #1077 among its holdings.

32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Prelude Capital Management held 10,300 shares of Instil Bio worth $84.9K as of Q1 2026.
  • Instil Bio was a new Prelude Capital Management position in Q1 2026.
  • Instil Bio made up 0.01% of Prelude Capital Management's portfolio in Q1 2026, its #1077 holding.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.